Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Pramlintide is the first FDA-approved synthetic insulin analog for the management of diabetes and can lead to a weight reduction of up to 7.9% in clinical use
People with inflammatory bowel disease
Kanoski and Grill, 2017)
The peptide's half-life is approximately 46 hours, so timed administration ensures peak plasma concentration coincides with peak receptor expression
US$ 25.67
US$ 20.03
US$ 24.52
US$ 27.04
US$ 25.50
US$ 21.22
US$ 25.43
US$ 23.46
US$ 24.63
US$ 24.16
US$ 28.20
US$ 25.06
